热门资讯> 正文
Aspire Bizerma任命新执行主席
2025-07-31 12:49
- Aspire Biopharma (NASDAQ:ASBP) said that Board of Directors has appointed Kraig Higginson as interim CEO, effective July 24, 2025.
- Mr. Higginson serves as Chairman of the Board and previously served as CEO of Aspire for four years.
- Michael C. Howe has resigned as CEO and as a member of the Board.
- The company and plans to initiate a search for a permanent CEO.
More on Aspire Biopharma Holdings, Inc.
- Financial information for Aspire Biopharma Holdings, Inc.
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。